Product Details

Remicade

Infliximab
100 mg/Vial
Powder for concentrate for solution for infusion

ROA

Intravenous

Applicant Name

J & J Company West Africa Limited

NRN

A6-0490

Status

Active


Composition

Each vial contains: Infliximab 100 mg After reconstitution, each mL contains: Infliximab 10 mg Infliximab is a chimeric human-murine IgG1 monoclonal antibody produced in murine hybridoma cells by recombinant DNA technology  

ATC Code/ATCvet Code

L04AB02  

Product Category

Vaccines and Biologics

Marketing Category

Prescription-only Medicine (POM)  

Packsize

1 x 1's (in vial)  

Product Description

Powder for concentrate for solution for infusion (powder for concentrate). The powder is a freeze-dried white pellet

Manufacturer Name

Cilag AG

Manufacturer Country

SWITZERLAND  

Approval Date

2023-06-27  

Expiry Date

2028-06-22